Balchem price target raised to $190 from $185 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Balchem (BCPC) to $190 from $185 and keeps a Buy rating on the shares post the Q3 report. The firm continues to consider Balchem a bright spot within the human and animal nutrition and health arena.